IP/patent seminar with Awapatent at Astra Zeneca
When? 9:30-12:00 on 14 March, 2017
Where? AstraZeneca Gothenburg (Pepparedsleden 1, Mölndal)
Sooner or later, as a successful pharma/biotech company, you’ll likely be subject to due-diligence. It’s good to know what ‘Big Pharma’ expect when it comes to IP generally and patents more specifically. Awapatent’s Christer Hällgren has a long experience of due diligence scenarios. At this seminar, Christer will share tips and tricks on how companies can be proactive and succeed better in future due diligence situations. Awapatent’s Niklas Mattsson will also share real-life stories and learnings from patent conflicts in the pharma and biotech industries. Surprising rulings, drastic consequences and large sums of money are just some of the experiences described from Sweden and abroad.